Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration

MeSH terms

• Blood Loss, Surgical
• Data Collection
• Data Interpretation, Statistical
• Heparin / therapeutic use
• Humans
• Platelet Aggregation Inhibitors / therapeutic use*
• Randomized Controlled Trials as Topic*
• Risk Factors
• Thromboembolism / prevention & control*
• Thrombophlebitis / prevention & control
• Treatment Outcome